Using adjuvant pharmacotherapy in the treatment of type 1 diabetes
| العنوان: | Using adjuvant pharmacotherapy in the treatment of type 1 diabetes |
|---|---|
| المؤلفون: | Åke SjöholmÅke Sjöholm |
| المصدر: | Expert Opinion on Pharmacotherapy. 22:2143-2148 |
| بيانات النشر: | Informa UK Limited, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Adult, endocrine system, medicine.medical_treatment, Amylin analog, Pharmacology, Diabetic Ketoacidosis, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Humans, Hypoglycemic Agents, Insulin, Medicine, Pharmacology (medical), Type 1 diabetes, business.industry, General Medicine, medicine.disease, Pramlintide, Metformin, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, 030220 oncology & carcinogenesis, business, Adjuvant, 030217 neurology & neurosurgery, medicine.drug |
| الوصف: | Introduction: Insulin and its analogues have so far been the only approved treatment for type 1 diabetes in Europe, while in the US, the amylin analog pramlintide is approved for adjuvant use with ... |
| تدمد: | 1744-7666 1465-6566 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d461e3254acfa3b9483a59acaf274bfTest https://doi.org/10.1080/14656566.2021.1939679Test |
| رقم الانضمام: | edsair.doi.dedup.....5d461e3254acfa3b9483a59acaf274bf |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 17447666 14656566 |
|---|